101 related articles for article (PubMed ID: 11257187)
1. Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins.
Okuma K; Matsuura Y; Tatsuo H; Inagaki Y; Nakamura M; Yamamoto N; Yanagi Y
J Gen Virol; 2001 Apr; 82(Pt 4):821-830. PubMed ID: 11257187
[TBL] [Abstract][Full Text] [Related]
2. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.
Tatsuo H; Okuma K; Tanaka K; Ono N; Minagawa H; Takade A; Matsuura Y; Yanagi Y
J Virol; 2000 May; 74(9):4139-45. PubMed ID: 10756026
[TBL] [Abstract][Full Text] [Related]
3. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
4. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H
Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060
[TBL] [Abstract][Full Text] [Related]
5. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test.
Ogino M; Ebihara H; Lee BH; Araki K; Lundkvist A; Kawaoka Y; Yoshimatsu K; Arikawa J
Clin Diagn Lab Immunol; 2003 Jan; 10(1):154-60. PubMed ID: 12522053
[TBL] [Abstract][Full Text] [Related]
6. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
7. Formation of vesicular stomatitis virus pseudotypes bearing surface proteins of hepatitis B virus.
Saha MN; Tanaka A; Jinno-Oue A; Shimizu N; Tamura K; Shinagawa M; Chiba J; Hoshino H
J Virol; 2005 Oct; 79(19):12566-74. PubMed ID: 16160184
[TBL] [Abstract][Full Text] [Related]
8. A system for functional analysis of Ebola virus glycoprotein.
Takada A; Robison C; Goto H; Sanchez A; Murti KG; Whitt MA; Kawaoka Y
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14764-9. PubMed ID: 9405687
[TBL] [Abstract][Full Text] [Related]
9. Pseudotypes of vesicular stomatitis virus-bearing envelope antigens of certain HIV-1 strains permissively infect human syncytiotrophoblasts cultured in vitro: implications for in vivo infection of syncytiotrophoblasts by cell-free HIV-1.
Bácsi A; Ebbesen P; Szabó J; Beck Z; Andirkó I; Csoma E; Tóth FD
J Med Virol; 2001 Aug; 64(4):387-97. PubMed ID: 11468721
[TBL] [Abstract][Full Text] [Related]
10. Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding.
Klenk K; Roberts SR
Virus Res; 2002 Dec; 90(1-2):327-35. PubMed ID: 12457986
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1.
Rogalin HB; Heldwein EE
J Virol; 2016 Nov; 90(22):10321-10328. PubMed ID: 27605677
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus.
Tani H; Iha K; Shimojima M; Fukushi S; Taniguchi S; Yoshikawa T; Kawaoka Y; Nakasone N; Ninomiya H; Saijo M; Morikawa S
J Virol; 2014 Jul; 88(13):7317-30. PubMed ID: 24741091
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer.
Meyer K; Beyene A; Bowlin TL; Basu A; Ray R
J Virol; 2004 Dec; 78(23):12838-47. PubMed ID: 15542636
[TBL] [Abstract][Full Text] [Related]
14. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.
Emi N; Friedmann T; Yee JK
J Virol; 1991 Mar; 65(3):1202-7. PubMed ID: 1847450
[TBL] [Abstract][Full Text] [Related]
15. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.
Meyer K; Basu A; Ray R
Virology; 2000 Oct; 276(1):214-26. PubMed ID: 11022009
[TBL] [Abstract][Full Text] [Related]
16. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
van den Pol AN; Mao G; Chattopadhyay A; Rose JK; Davis JN
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077641
[TBL] [Abstract][Full Text] [Related]
17. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
Majid AM; Ezelle H; Shah S; Barber GN
J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
[TBL] [Abstract][Full Text] [Related]
18. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
Haglund K; Forman J; Kräusslich HG; Rose JK
Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
[TBL] [Abstract][Full Text] [Related]
19. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
[TBL] [Abstract][Full Text] [Related]
20. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice.
Lee BH; Yoshimatsu K; Araki K; Okumura M; Nakamura I; Arikawa J
Vaccine; 2006 Apr; 24(15):2928-34. PubMed ID: 16426712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
